Comparable indicators of therapeutic misconception between epilepsy or Parkinson's disease patients between those with clinical trial experience and trial non-participants
- PMID: 29908425
- DOI: 10.1016/j.seizure.2018.06.006
Comparable indicators of therapeutic misconception between epilepsy or Parkinson's disease patients between those with clinical trial experience and trial non-participants
Abstract
Purpose: Study design, personal persuasions, and experiences can influence willingness to participate in clinical trials (CTs). A study assessed differences between Parkinson's disease (PD) or epilepsy patients having participated in CTs and non-participants in knowledge of and attitudes toward CTs. Also considered were factors in willingness to take part and how CT participants experienced the informed consent process.
Method: Random samples of members of Finland's PD (n = 2000) and epilepsy (n = 1875) patient organisations were posted a questionnaire on their views about CTs. Of the 1050 questionnaires returned, 845 met inclusion criteria. In total, 126 had participated in CTs.
Results: While over 90% of respondents knew that participation is always voluntary, CT participants were more often aware that one can withdraw (p<0.001). In both groups, most did not recognise the possibility of randomisation, and 57% in both CT participants and non-participants indicated that CTs are aimed primarily at seeking the best medication for the participant. Nevertheless, 83% of CT participants indicated ability to understand the information provided.
Conclusions: While most in our study agreed that patients should be asked to participate in CTs, only 15% of subjects had done so. The discrepancy between willingness to participate and recruitment figures could be minimised by improving knowledge of CTs and communication between patients and researchers. Additionally, the groups displayed comparable false CT-related assumptions, raising questions about whether these subjects fully understood the clinical research's ultimate goal and CT participants had given true informed consent. These issues have practical and ethics implications for clinical investigators.
Keywords: Clinical trials; Epilepsy; Informed consent process; Parkinson’s disease; Therapeutic misconception; Trial participation.
Copyright © 2018 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Clinical features of Parkinson's disease patients are associated with therapeutic misconception and willingness to participate in clinical trials.Trials. 2017 Sep 29;18(1):444. doi: 10.1186/s13063-017-2174-2. Trials. 2017. PMID: 28962634 Free PMC article.
-
Therapeutic misconception correlates with willingness to participate in clinical drug trials among patients with epilepsy; need for better counseling.Epilepsy Behav. 2015 Jul;48:29-34. doi: 10.1016/j.yebeh.2015.05.013. Epub 2015 May 31. Epilepsy Behav. 2015. PMID: 26037846
-
What motivates Parkinson's disease patients to enter clinical trials?Parkinsonism Relat Disord. 2011 Nov;17(9):667-71. doi: 10.1016/j.parkreldis.2011.05.023. Epub 2011 Jun 28. Parkinsonism Relat Disord. 2011. PMID: 21715213
-
Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention.Neurotherapeutics. 2020 Oct;17(4):1724-1735. doi: 10.1007/s13311-020-00960-0. Epub 2020 Nov 4. Neurotherapeutics. 2020. PMID: 33150545 Free PMC article. Review.
-
Clinical research: what do patients understand?Orthop Nurs. 2000 Mar-Apr;19(2):95-9. doi: 10.1097/00006416-200019020-00013. Orthop Nurs. 2000. PMID: 11062641 Review.
Cited by
-
Specialized Smartphone Intervention Apps: Review of 2014 to 2018 NIH Funded Grants.JMIR Mhealth Uhealth. 2019 Jul 29;7(7):e14655. doi: 10.2196/14655. JMIR Mhealth Uhealth. 2019. PMID: 31359866 Free PMC article. Review.
-
"I Want to Do It, But I Want to Make Sure That I Do It Right." Views of Patients with Parkinson's Disease Regarding Early Stem Cell Clinical Trial Participation.AJOB Empir Bioeth. 2020 Jul-Sep;11(3):160-171. doi: 10.1080/23294515.2020.1775721. Epub 2020 Jun 9. AJOB Empir Bioeth. 2020. PMID: 32516056 Free PMC article.
-
Positive Attitudes and Therapeutic Misconception Around Hypothetical Clinical Trial Participation in the Huntington's Disease Community.J Huntingtons Dis. 2019;8(4):421-430. doi: 10.3233/JHD-190382. J Huntingtons Dis. 2019. PMID: 31594242 Free PMC article.
-
Participants' understanding of informed consent in clinical trials: A systematic review and updated meta-analysis.PLoS One. 2024 Jan 2;19(1):e0295784. doi: 10.1371/journal.pone.0295784. eCollection 2024. PLoS One. 2024. Retraction in: PLoS One. 2025 Jun 3;20(6):e0325694. doi: 10.1371/journal.pone.0325694. PMID: 38166097 Free PMC article. Retracted.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous